Home/Products /paclitaxel-ip-6mg-polyoxyl-35-castor-oil-ip-527mg-dehydrtes-alcohol-ip-49-7-v-v-100mg-injection

Packlin 100 injection: Paclitaxel 100 mg - Institutional Chemotherapy

Name: Packlin 100: Paclitaxel Injection 100 mg
Brand: Packlin 100 Injection
Rating: 4.8 (150 reviews)

Microtubule Stabilization: The Anti-Cancer Mechanism of Paclitaxel (Taxane)

Primary Indication: First-line and Adjuvant Therapy for Breast and Ovarian Cancer

Flexible Dosing: Ideal 100 mg Vial Size for Hospital Pharmacy Management

Important: Specialized Administration and Pre-medication Protocol

Secure Your Monopoly: Packlin 100 PCD Pharma Franchise in Injectable Oncology

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Stimulant

Urology

Paclitaxel 100 mg injection vial for chemotherapy

Hospital pharmacy inventory of oncology injectables

Oncology PCD Pharma franchise marketing visual for injectable Paclitaxel

Packlin 100 injection (Paclitaxel) Administration and Stability Protocol PDF

Packlin 100 Injection

Composition : Paclitaxel IP 6mg + Polyoxyl 35 Castor oil IP 527mg + Dehydrtes Alcohol IP 49.7% v/v

Dosage Form : Injection

Packaging Type : Vial

Packaging : 100 gm

Price : ₹0/-

Please Contact For Best Price

Packlin 100 injection is a high-potency, intravenous chemotherapy solution containing Paclitaxel , an essential drug in the Taxane class. This $100 mg$ presentation is often preferred in hospital settings for dose flexibility and minimizing drug wastage, making it a high-demand inventory item.

Mechanism and Impact:Paclitaxel is a cytotoxic agent that promotes the assembly of microtubules and stabilizes them, inhibiting the normal cell division process. This action prevents the necessary restructuring of the microtubule network required for cell division, thereby leading to the arrest of mitosis and the eventual death of rapidly dividing cancer cells.

Key Therapeutic Uses:

Breast Cancer: Used in adjuvant, neoadjuvant, and metastatic settings.
Ovarian Cancer: Standard treatment for advanced ovarian carcinoma.
Non-Small Cell Lung Cancer (NSCLC): Used in combination regimens.
Kaposi's Sarcoma: For advanced cases unresponsive to prior therapy.

The demand for Paclitaxel is reliable and sustained, driven entirely by institutional prescribing. We offer an exclusive PCD Pharma Franchise opportunity for Packlin 100 injection, enabling partners to secure a dominant position in the highly competitive injectable oncology market through a convenient and in-demand vial size.

About the Product

Key Therapeutic Uses:

Breast Cancer: Used in adjuvant, neoadjuvant, and metastatic settings.
Ovarian Cancer: Standard treatment for advanced ovarian carcinoma.
Non-Small Cell Lung Cancer (NSCLC): Used in combination regimens.
Kaposi's Sarcoma: For advanced cases unresponsive to prior therapy.

Hair loss (alopecia) Nausea, vomiting, diarrhea Low blood counts (anemia, leukopenia) Peripheral neuropathy (tingling or numbness) Joint/muscle pain

Metastatic breast cancer Advanced ovarian carcinoma Non-small cell lung cancer (NSCLC) AIDS-related Kaposi’s sarcoma Often used as first-line or second-line therapy, either alone or in combination with other chemotherapeutic agents like cisplatin.

Administered intravenously by trained professionals in a clinical setting. Premedication with corticosteroids, antihistamines, and H2 antagonists is essential to minimize hypersensitivity reactions. Requires close monitoring of blood counts, liver function, and cardiac status.

Store below 25°C, protected from light. Do not freeze. Shake well before use. Keep out of reach of children.